[ad_1]
Cottonbro
Illustration of the Covid-19 vaccine
GridHype.ID – The coronavirus vaccine finally came back positive after testing some time ago.
Hospitals in Chicago, United States of America (USA) treat seriously ill patients of Covid-19 with remdesivir of antiviral drugs released by the American biotechnology company Gilead Sciences Inc. in clinical trials.
The clinical trial was closely monitored for rapid recovery from fever and respiratory symptoms, with almost all patients discharged in less than a week.
By launching STAT News, remdesivir was one of the first drugs identified that has the potential to impact SARS-CoV-2, a new type of coronavirus that causes Covid-19 in laboratory tests.
Also read: Although it destroyed the hope of many people, Najwa Shihab opened the eyes of many parts to the prediction when the Corona virus pandemic in Indonesia ends: it is impossible for us to know!
The results of Gilead’s clinical trials are highly anticipated.
And the positive results are likely to lead to swift approval by the Food and Drug Administration and other drug regulatory and regulatory agencies.
If it is safe and effective, it may be a first-time approved treatment for Covid-19 disease.
The University of Chicago Department of Medicine recruited 125 people with Covid-19 in two Gilead phase 3 clinical trials.
Of these people, 113 had serious illnesses, all the patients had been treated with infusions of remdesivir every day.
Featured videos
->
PROMOTIONAL CONTENT
